J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer

"New 'Breakthrough' Alzheimer's Drug Approved: Slows Brain Decline By 27%, But $26,500/Year Pricing Controversial

University Hospital Heidelberg, Germany

New Drug For IDH1 Mutation/Relapsed/Refractory Acute Myeloid Leukaemia With Good Complete Remission Rates And Manageable Toxicity

Airway Announces First Patient To Receive Dose In Bpd Trial

Watch Out For The Me Better 'Trap' Behind The Changing Future Of Frα Adc Rising Stars